Soligenix, Inc.
SNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000812796
No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Soligenix, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +3 vs. Q1 2026
- Shares held
- 933.5K
- +673.0K (+258.3%) vs. Q1 2026
- Total value
- $369.6K
- +$62.1K (+20.2%) vs. Q1 2026
- New holders
- 6
- 3 more added
- Sold out
- 3
- 3 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $369.6K |
| Q1 2026 | 15 | $307.4K |
| Q4 2025 | 19 | $600.0K |
| Q3 2025 | 23 | $1.61M |
| Q2 2025 | 15 | $248.2K |
| Q1 2025 | 11 | $313.1K |
| Q4 2024 | 10 | $82.8K |
| Q3 2024 | 7 | $262.4K |
| Q2 2024 | 11 | $259.1K |
| Q1 2024 | 18 | $143.0K |
| Q4 2023 | 20 | $286.5K |
| Q3 2023 | 19 | $500.2K |
| Q2 2023 | 20 | $1.02M |
| Q1 2023 | 16 | $195.2K |
| Q4 2022 | 36 | $1.37M |
| Q3 2022 | 30 | $1.35M |
| Q2 2022 | 28 | $1.91M |
| Q1 2022 | 33 | $2.38M |
| Q4 2021 | 28 | $2.24M |
| Q3 2021 | 34 | $4.35M |
| Q2 2021 | 34 | $4.59M |
| Q1 2021 | 35 | $5.22M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Soligenix, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 1 | $0 | 0.00% | −1−50.0% | Reduced |
| Royal Bank of Canada | 5 | $0 | 0.00% | +5 | New |
| Caitong International Asset Management Co., Ltd | 1 | $0 | 0.00% | +1 | New |
| SBI Securities Co., Ltd. | 2 | $1 | 0.00% | −400−99.5% | Reduced |
| Albion Financial Group | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 209 | $83 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 245 | $98 | 0.00% | −60−19.7% | Reduced |
| Jones Financial Companies LLLP | 1,236 | $507 | 0.00% | +1,136+1,136.0% | Added |
| Morgan Stanley | 3,592 | $1.42K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 38,046 | $15.1K | 0.00% | +38,046 | New |
| Vanguard Fiduciary Trust Co | 53,914 | $21.4K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 60,903 | $24.0K | 0.00% | +60,903 | New |
| Vanguard Capital Management LLC | 81,005 | $32.1K | 0.00% | +22,605+38.7% | Added |
| Geode Capital Management, LLC | 120,267 | $47.6K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 157,119 | $62.2K | 0.00% | +136,320+655.4% | Added |
| Jane Street Group, LLC | 207,492 | $82.2K | 0.00% | +207,492 | New |
| Citadel Advisors LLC | 209,507 | $83.0K | 0.00% | +209,507 | New |
| UBS Group AG | 0 | $0 | 0.00% | −2,346−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −209−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |